Industry Research Reports
Global Crude Heparin Market Insights, Forecast to 2030
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Crude Heparin Market Size(US$)
CAGR 2024-2030
6.2%
Market Size,2030
USD 5,474.4
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 3,818 million
Market Forecast in 2030(Value)
US$ 5,474.4 million
CAGR
6.2%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
The global Crude Heparin market is projected to grow from US$ 3818 million in 2024 to US$ 5474.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period.
Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Fengrun Biological Technology. The top three players hold a share about 30%. The global crude heparin products are mainly produced in Europe and China. Asia-Pacific is the largest market, has a share about 57%, followed by North America and Europe, with share 21% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 90%.
Report Covers:
This report presents an overview of global market for Crude Heparin, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Crude Heparin, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Crude Heparin, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Crude Heparin sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Crude Heparin market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Crude Heparin sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
- Bioiberica
- Shenzhen Hepalink
- Sanofi
- Nanjing King-friend
- Fengrun Biological Technology
- Aspen Oss
- Hebei Changshan Biochemical
- Changzhou Qianhong
- Hepac (Darling Ingredients)
- Huaian MDC Pharmaceutical
- Yantai Dongcheng Biochemicals
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Pig Intestine Mucosa Heparin
- Bovine Heparin and Others
Segment by Application
- UFH
- LMWH
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Crude Heparin in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Crude Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crude Heparin sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYResearch's Strengths
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
Table of Contents
1 Study Coverage
1.1 Crude Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Crude Heparin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Market by Application
1.3.1 Global Crude Heparin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 UFH
1.3.3 LMWH
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Crude Heparin Sales Estimates and Forecasts 2019-2030
2.2 Global Crude Heparin Revenue by Region
2.2.1 Global Crude Heparin Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Crude Heparin Revenue by Region (2019-2024)
2.2.3 Global Crude Heparin Revenue by Region (2025-2030)
2.2.4 Global Crude Heparin Revenue Market Share by Region (2019-2030)
2.3 Global Crude Heparin Sales Estimates and Forecasts 2019-2030
2.4 Global Crude Heparin Sales by Region
2.4.1 Global Crude Heparin Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Crude Heparin Sales by Region (2019-2024)
2.4.3 Global Crude Heparin Sales by Region (2025-2030)
2.4.4 Global Crude Heparin Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Crude Heparin Sales by Manufacturers
3.1.1 Global Crude Heparin Sales by Manufacturers (2019-2024)
3.1.2 Global Crude Heparin Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Crude Heparin in 2023
3.2 Global Crude Heparin Revenue by Manufacturers
3.2.1 Global Crude Heparin Revenue by Manufacturers (2019-2024)
3.2.2 Global Crude Heparin Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Crude Heparin Revenue in 2023
3.3 Global Key Players of Crude Heparin, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Crude Heparin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Crude Heparin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Crude Heparin, Product Offered and Application
3.8 Global Key Manufacturers of Crude Heparin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Crude Heparin Sales by Type
4.1.1 Global Crude Heparin Historical Sales by Type (2019-2024)
4.1.2 Global Crude Heparin Forecasted Sales by Type (2025-2030)
4.1.3 Global Crude Heparin Sales Market Share by Type (2019-2030)
4.2 Global Crude Heparin Revenue by Type
4.2.1 Global Crude Heparin Historical Revenue by Type (2019-2024)
4.2.2 Global Crude Heparin Forecasted Revenue by Type (2025-2030)
4.2.3 Global Crude Heparin Revenue Market Share by Type (2019-2030)
4.3 Global Crude Heparin Price by Type
4.3.1 Global Crude Heparin Price by Type (2019-2024)
4.3.2 Global Crude Heparin Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Crude Heparin Sales by Application
5.1.1 Global Crude Heparin Historical Sales by Application (2019-2024)
5.1.2 Global Crude Heparin Forecasted Sales by Application (2025-2030)
5.1.3 Global Crude Heparin Sales Market Share by Application (2019-2030)
5.2 Global Crude Heparin Revenue by Application
5.2.1 Global Crude Heparin Historical Revenue by Application (2019-2024)
5.2.2 Global Crude Heparin Forecasted Revenue by Application (2025-2030)
5.2.3 Global Crude Heparin Revenue Market Share by Application (2019-2030)
5.3 Global Crude Heparin Price by Application
5.3.1 Global Crude Heparin Price by Application (2019-2024)
5.3.2 Global Crude Heparin Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Crude Heparin Market Size by Type
6.1.1 US & Canada Crude Heparin Sales by Type (2019-2030)
6.1.2 US & Canada Crude Heparin Revenue by Type (2019-2030)
6.2 US & Canada Crude Heparin Market Size by Application
6.2.1 US & Canada Crude Heparin Sales by Application (2019-2030)
6.2.2 US & Canada Crude Heparin Revenue by Application (2019-2030)
6.3 US & Canada Crude Heparin Market Size by Country
6.3.1 US & Canada Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Crude Heparin Sales by Country (2019-2030)
6.3.3 US & Canada Crude Heparin Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Crude Heparin Market Size by Type
7.1.1 Europe Crude Heparin Sales by Type (2019-2030)
7.1.2 Europe Crude Heparin Revenue by Type (2019-2030)
7.2 Europe Crude Heparin Market Size by Application
7.2.1 Europe Crude Heparin Sales by Application (2019-2030)
7.2.2 Europe Crude Heparin Revenue by Application (2019-2030)
7.3 Europe Crude Heparin Market Size by Country
7.3.1 Europe Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Crude Heparin Sales by Country (2019-2030)
7.3.3 Europe Crude Heparin Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Crude Heparin Market Size
8.1.1 China Crude Heparin Sales (2019-2030)
8.1.2 China Crude Heparin Revenue (2019-2030)
8.2 China Crude Heparin Market Size by Application
8.2.1 China Crude Heparin Sales by Application (2019-2030)
8.2.2 China Crude Heparin Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Crude Heparin Market Size by Type
9.1.1 Asia Crude Heparin Sales by Type (2019-2030)
9.1.2 Asia Crude Heparin Revenue by Type (2019-2030)
9.2 Asia Crude Heparin Market Size by Application
9.2.1 Asia Crude Heparin Sales by Application (2019-2030)
9.2.2 Asia Crude Heparin Revenue by Application (2019-2030)
9.3 Asia Crude Heparin Sales by Region
9.3.1 Asia Crude Heparin Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Crude Heparin Revenue by Region (2019-2030)
9.3.3 Asia Crude Heparin Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Crude Heparin Market Size by Type
10.1.1 Middle East, Africa and Latin America Crude Heparin Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Crude Heparin Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Crude Heparin Market Size by Application
10.2.1 Middle East, Africa and Latin America Crude Heparin Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Crude Heparin Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Crude Heparin Sales by Country
10.3.1 Middle East, Africa and Latin America Crude Heparin Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Crude Heparin Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Crude Heparin Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bioiberica
11.1.1 Bioiberica Company Information
11.1.2 Bioiberica Overview
11.1.3 Bioiberica Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bioiberica Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bioiberica Recent Developments
11.2 Shenzhen Hepalink
11.2.1 Shenzhen Hepalink Company Information
11.2.2 Shenzhen Hepalink Overview
11.2.3 Shenzhen Hepalink Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Shenzhen Hepalink Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Shenzhen Hepalink Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Information
11.3.2 Sanofi Overview
11.3.3 Sanofi Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Sanofi Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Sanofi Recent Developments
11.4 Nanjing King-friend
11.4.1 Nanjing King-friend Company Information
11.4.2 Nanjing King-friend Overview
11.4.3 Nanjing King-friend Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Nanjing King-friend Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nanjing King-friend Recent Developments
11.5 Fengrun Biological Technology
11.5.1 Fengrun Biological Technology Company Information
11.5.2 Fengrun Biological Technology Overview
11.5.3 Fengrun Biological Technology Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Fengrun Biological Technology Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fengrun Biological Technology Recent Developments
11.6 Aspen Oss
11.6.1 Aspen Oss Company Information
11.6.2 Aspen Oss Overview
11.6.3 Aspen Oss Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Aspen Oss Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Aspen Oss Recent Developments
11.7 Hebei Changshan Biochemical
11.7.1 Hebei Changshan Biochemical Company Information
11.7.2 Hebei Changshan Biochemical Overview
11.7.3 Hebei Changshan Biochemical Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Hebei Changshan Biochemical Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hebei Changshan Biochemical Recent Developments
11.8 Changzhou Qianhong
11.8.1 Changzhou Qianhong Company Information
11.8.2 Changzhou Qianhong Overview
11.8.3 Changzhou Qianhong Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Changzhou Qianhong Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Changzhou Qianhong Recent Developments
11.9 Hepac (Darling Ingredients)
11.9.1 Hepac (Darling Ingredients) Company Information
11.9.2 Hepac (Darling Ingredients) Overview
11.9.3 Hepac (Darling Ingredients) Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Hepac (Darling Ingredients) Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Hepac (Darling Ingredients) Recent Developments
11.10 Huaian MDC Pharmaceutical
11.10.1 Huaian MDC Pharmaceutical Company Information
11.10.2 Huaian MDC Pharmaceutical Overview
11.10.3 Huaian MDC Pharmaceutical Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Huaian MDC Pharmaceutical Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Huaian MDC Pharmaceutical Recent Developments
11.11 Yantai Dongcheng Biochemicals
11.11.1 Yantai Dongcheng Biochemicals Company Information
11.11.2 Yantai Dongcheng Biochemicals Overview
11.11.3 Yantai Dongcheng Biochemicals Crude Heparin Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Yantai Dongcheng Biochemicals Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Yantai Dongcheng Biochemicals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Crude Heparin Industry Chain Analysis
12.2 Crude Heparin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Crude Heparin Production Mode & Process
12.4 Crude Heparin Sales and Marketing
12.4.1 Crude Heparin Sales Channels
12.4.2 Crude Heparin Distributors
12.5 Crude Heparin Customers
13 Market Dynamics
13.1 Crude Heparin Industry Trends
13.2 Crude Heparin Market Drivers
13.3 Crude Heparin Market Challenges
13.4 Crude Heparin Market Restraints
14 Key Findings in The Global Crude Heparin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Crude Heparin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Pig Intestine Mucosa Heparin
Table 3. Major Manufacturers of Bovine Heparin and Others
Table 4. Global Crude Heparin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 5. Global Crude Heparin Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 6. Global Crude Heparin Revenue by Region (2019-2024) & (US$ Million)
Table 7. Global Crude Heparin Revenue by Region (2025-2030) & (US$ Million)
Table 8. Global Crude Heparin Revenue Market Share by Region (2019-2024)
Table 9. Global Crude Heparin Revenue Market Share by Region (2025-2030)
Table 10. Global Crude Heparin Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 11. Global Crude Heparin Sales by Region (2019-2024) & (Tons)
Table 12. Global Crude Heparin Sales by Region (2025-2030) & (Tons)
Table 13. Global Crude Heparin Sales Market Share by Region (2019-2024)
Table 14. Global Crude Heparin Sales Market Share by Region (2025-2030)
Table 15. Global Crude Heparin Sales by Manufacturers (2019-2024) & (Tons)
Table 16. Global Crude Heparin Sales Share by Manufacturers (2019-2024)
Table 17. Global Crude Heparin Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 18. Global Crude Heparin Revenue Share by Manufacturers (2019-2024)
Table 19. Global Key Players of Crude Heparin, Industry Ranking, 2022 VS 2023 VS 2024
Table 20. Crude Heparin Price by Manufacturers 2019-2024 (US$/Kg)
Table 21. Global Crude Heparin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Crude Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2023)
Table 23. Global Key Manufacturers of Crude Heparin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Crude Heparin, Product Offered and Application
Table 25. Global Key Manufacturers of Crude Heparin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 28. Global Crude Heparin Sales by Type (2025-2030) & (Tons)
Table 29. Global Crude Heparin Sales Share by Type (2019-2024)
Table 30. Global Crude Heparin Sales Share by Type (2025-2030)
Table 31. Global Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 32. Global Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 33. Global Crude Heparin Revenue Share by Type (2019-2024)
Table 34. Global Crude Heparin Revenue Share by Type (2025-2030)
Table 35. Crude Heparin Price by Type (2019-2024) & (US$/Kg)
Table 36. Global Crude Heparin Price Forecast by Type (2025-2030) & (US$/Kg)
Table 37. Global Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 38. Global Crude Heparin Sales by Application (2025-2030) & (Tons)
Table 39. Global Crude Heparin Sales Share by Application (2019-2024)
Table 40. Global Crude Heparin Sales Share by Application (2025-2030)
Table 41. Global Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 42. Global Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 43. Global Crude Heparin Revenue Share by Application (2019-2024)
Table 44. Global Crude Heparin Revenue Share by Application (2025-2030)
Table 45. Crude Heparin Price by Application (2019-2024) & (US$/Kg)
Table 46. Global Crude Heparin Price Forecast by Application (2025-2030) & (US$/Kg)
Table 47. US & Canada Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 48. US & Canada Crude Heparin Sales by Type (2025-2030) & (Tons)
Table 49. US & Canada Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 50. US & Canada Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 51. US & Canada Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 52. US & Canada Crude Heparin Sales by Application (2025-2030) & (Tons)
Table 53. US & Canada Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 54. US & Canada Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 55. US & Canada Crude Heparin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 56. US & Canada Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 57. US & Canada Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 58. US & Canada Crude Heparin Sales by Country (2019-2024) & (Tons)
Table 59. US & Canada Crude Heparin Sales by Country (2025-2030) & (Tons)
Table 60. Europe Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 61. Europe Crude Heparin Sales by Type (2025-2030) & (Tons)
Table 62. Europe Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 63. Europe Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 64. Europe Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 65. Europe Crude Heparin Sales by Application (2025-2030) & (Tons)
Table 66. Europe Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 67. Europe Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 68. Europe Crude Heparin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 69. Europe Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 70. Europe Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 71. Europe Crude Heparin Sales by Country (2019-2024) & (Tons)
Table 72. Europe Crude Heparin Sales by Country (2025-2030) & (Tons)
Table 73. China Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 74. China Crude Heparin Sales by Type (2025-2030) & (Tons)
Table 75. China Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 76. China Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 77. China Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 78. China Crude Heparin Sales by Application (2025-2030) & (Tons)
Table 79. China Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 80. China Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 81. Asia Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 82. Asia Crude Heparin Sales by Type (2025-2030) & (Tons)
Table 83. Asia Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 84. Asia Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 85. Asia Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 86. Asia Crude Heparin Sales by Application (2025-2030) & (Tons)
Table 87. Asia Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 88. Asia Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 89. Asia Crude Heparin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 90. Asia Crude Heparin Revenue by Region (2019-2024) & (US$ Million)
Table 91. Asia Crude Heparin Revenue by Region (2025-2030) & (US$ Million)
Table 92. Asia Crude Heparin Sales by Region (2019-2024) & (Tons)
Table 93. Asia Crude Heparin Sales by Region (2025-2030) & (Tons)
Table 94. Middle East, Africa and Latin America Crude Heparin Sales by Type (2019-2024) & (Tons)
Table 95. Middle East, Africa and Latin America Crude Heparin Sales by Type (2025-2030) & (Tons)
Table 96. Middle East, Africa and Latin America Crude Heparin Revenue by Type (2019-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Crude Heparin Revenue by Type (2025-2030) & (US$ Million)
Table 98. Middle East, Africa and Latin America Crude Heparin Sales by Application (2019-2024) & (Tons)
Table 99. Middle East, Africa and Latin America Crude Heparin Sales by Application (2025-2030) & (Tons)
Table 100. Middle East, Africa and Latin America Crude Heparin Revenue by Application (2019-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Crude Heparin Revenue by Application (2025-2030) & (US$ Million)
Table 102. Middle East, Africa and Latin America Crude Heparin Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 103. Middle East, Africa and Latin America Crude Heparin Revenue by Country (2019-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Crude Heparin Revenue by Country (2025-2030) & (US$ Million)
Table 105. Middle East, Africa and Latin America Crude Heparin Sales by Country (2019-2024) & (Tons)
Table 106. Middle East, Africa and Latin America Crude Heparin Sales by Country (2025-2030) & (Tons)
Table 107. Bioiberica Company Information
Table 108. Bioiberica Description and Major Businesses
Table 109. Bioiberica Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 110. Bioiberica Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Bioiberica Recent Developments
Table 112. Shenzhen Hepalink Company Information
Table 113. Shenzhen Hepalink Description and Major Businesses
Table 114. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 115. Shenzhen Hepalink Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Shenzhen Hepalink Recent Developments
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Major Businesses
Table 119. Sanofi Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 120. Sanofi Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Sanofi Recent Developments
Table 122. Nanjing King-friend Company Information
Table 123. Nanjing King-friend Description and Major Businesses
Table 124. Nanjing King-friend Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 125. Nanjing King-friend Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Nanjing King-friend Recent Developments
Table 127. Fengrun Biological Technology Company Information
Table 128. Fengrun Biological Technology Description and Major Businesses
Table 129. Fengrun Biological Technology Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 130. Fengrun Biological Technology Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Fengrun Biological Technology Recent Developments
Table 132. Aspen Oss Company Information
Table 133. Aspen Oss Description and Major Businesses
Table 134. Aspen Oss Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 135. Aspen Oss Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Aspen Oss Recent Developments
Table 137. Hebei Changshan Biochemical Company Information
Table 138. Hebei Changshan Biochemical Description and Major Businesses
Table 139. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 140. Hebei Changshan Biochemical Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hebei Changshan Biochemical Recent Developments
Table 142. Changzhou Qianhong Company Information
Table 143. Changzhou Qianhong Description and Major Businesses
Table 144. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 145. Changzhou Qianhong Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Changzhou Qianhong Recent Developments
Table 147. Hepac (Darling Ingredients) Company Information
Table 148. Hepac (Darling Ingredients) Description and Major Businesses
Table 149. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 150. Hepac (Darling Ingredients) Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Hepac (Darling Ingredients) Recent Developments
Table 152. Huaian MDC Pharmaceutical Company Information
Table 153. Huaian MDC Pharmaceutical Description and Major Businesses
Table 154. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 155. Huaian MDC Pharmaceutical Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Huaian MDC Pharmaceutical Recent Developments
Table 157. Yantai Dongcheng Biochemicals Company Information
Table 158. Yantai Dongcheng Biochemicals Description and Major Businesses
Table 159. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 160. Yantai Dongcheng Biochemicals Crude Heparin Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Yantai Dongcheng Biochemicals Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Crude Heparin Distributors List
Table 165. Crude Heparin Customers List
Table 166. Crude Heparin Market Trends
Table 167. Crude Heparin Market Drivers
Table 168. Crude Heparin Market Challenges
Table 169. Crude Heparin Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Crude Heparin Product Picture
Figure 2. Global Crude Heparin Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Crude Heparin Market Share by Type in 2023 & 2030
Figure 4. Pig Intestine Mucosa Heparin Product Picture
Figure 5. Bovine Heparin and Others Product Picture
Figure 6. Global Crude Heparin Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 7. Global Crude Heparin Market Share by Application in 2023 & 2030
Figure 8. UFH
Figure 9. LMWH
Figure 10. Crude Heparin Report Years Considered
Figure 11. Global Crude Heparin Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Crude Heparin Revenue 2019-2030 (US$ Million)
Figure 13. Global Crude Heparin Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 14. Global Crude Heparin Revenue Market Share by Region (2019-2030)
Figure 15. Global Crude Heparin Sales 2019-2030 ((Tons)
Figure 16. Global Crude Heparin Sales Market Share by Region (2019-2030)
Figure 17. US & Canada Crude Heparin Sales YoY (2019-2030) & (Tons)
Figure 18. US & Canada Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 19. Europe Crude Heparin Sales YoY (2019-2030) & (Tons)
Figure 20. Europe Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 21. China Crude Heparin Sales YoY (2019-2030) & (Tons)
Figure 22. China Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 23. Asia (excluding China) Crude Heparin Sales YoY (2019-2030) & (Tons)
Figure 24. Asia (excluding China) Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Crude Heparin Sales YoY (2019-2030) & (Tons)
Figure 26. Middle East, Africa and Latin America Crude Heparin Revenue YoY (2019-2030) & (US$ Million)
Figure 27. The Crude Heparin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
Figure 28. The Top 5 and 10 Largest Manufacturers of Crude Heparin in the World: Market Share by Crude Heparin Revenue in 2023
Figure 29. Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 30. Global Crude Heparin Sales Market Share by Type (2019-2030)
Figure 31. Global Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 32. Global Crude Heparin Sales Market Share by Application (2019-2030)
Figure 33. Global Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 34. US & Canada Crude Heparin Sales Market Share by Type (2019-2030)
Figure 35. US & Canada Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 36. US & Canada Crude Heparin Sales Market Share by Application (2019-2030)
Figure 37. US & Canada Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 38. US & Canada Crude Heparin Revenue Share by Country (2019-2030)
Figure 39. US & Canada Crude Heparin Sales Share by Country (2019-2030)
Figure 40. U.S. Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 41. Canada Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 42. Europe Crude Heparin Sales Market Share by Type (2019-2030)
Figure 43. Europe Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 44. Europe Crude Heparin Sales Market Share by Application (2019-2030)
Figure 45. Europe Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 46. Europe Crude Heparin Revenue Share by Country (2019-2030)
Figure 47. Europe Crude Heparin Sales Share by Country (2019-2030)
Figure 48. Germany Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 49. France Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 50. U.K. Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 51. Italy Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 52. Russia Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 53. China Crude Heparin Sales Market Share by Type (2019-2030)
Figure 54. China Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 55. China Crude Heparin Sales Market Share by Application (2019-2030)
Figure 56. China Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 57. Asia Crude Heparin Sales Market Share by Type (2019-2030)
Figure 58. Asia Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 59. Asia Crude Heparin Sales Market Share by Application (2019-2030)
Figure 60. Asia Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 61. Asia Crude Heparin Revenue Share by Region (2019-2030)
Figure 62. Asia Crude Heparin Sales Share by Region (2019-2030)
Figure 63. Japan Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 64. South Korea Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 65. China Taiwan Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 66. Southeast Asia Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 67. India Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Crude Heparin Sales Market Share by Type (2019-2030)
Figure 69. Middle East, Africa and Latin America Crude Heparin Revenue Market Share by Type (2019-2030)
Figure 70. Middle East, Africa and Latin America Crude Heparin Sales Market Share by Application (2019-2030)
Figure 71. Middle East, Africa and Latin America Crude Heparin Revenue Market Share by Application (2019-2030)
Figure 72. Middle East, Africa and Latin America Crude Heparin Revenue Share by Country (2019-2030)
Figure 73. Middle East, Africa and Latin America Crude Heparin Sales Share by Country (2019-2030)
Figure 74. Brazil Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 75. Mexico Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 76. Turkey Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 77. Israel Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 78. GCC Countries Crude Heparin Revenue (2019-2030) & (US$ Million)
Figure 79. Crude Heparin Value Chain
Figure 80. Crude Heparin Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Related Reports
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-16
Pages: 147
USD 5900.00
(Single User License)
Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published Date: 2024-04-17
Pages: 159
USD 5600.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-01-18
Pages: 128
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-18
Pages: 88
USD 2900.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 155
USD 5900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 100
USD 4250.00
(Single User License)
Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-10
Pages: 164
USD 4900.00
(Single User License)
Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 112
USD 3950.00
(Single User License)
Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 124
USD 2900.00
(Single User License)
Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 95
USD 4250.00
(Single User License)
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-16
Pages: 147
USD 5900.00 (Single User License)Global Crude Heparin Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Heparin is one of the oldest drugs currently in widespread clinical use. It was originally isolated from canine liver cells. Heparin was discovered by Jay McLean and William Henry Howell in 1916. Heparin prevents the blood from clotting and is used to treat and prevent deep vein thrombosis and pulmonary embolism. It is also used as part of the treatment of myocardial infarction and unstable angina. Another application of heparin is an inner surface anticoagulant on various experimental and medical devices such as test tubes and renal dialysis machines. Crude heparin is the starting material intended for further processing by FDA drug establishments into heparin sodium USP API (active pharmaceutical ingredient), not a finished drug product. The scope of this report is mainly about Crude Heparin, Crude heparin is the upstream raw material for heparin.
Published: 2024-04-17
Pages: 159
USD 5600.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Crude Heparin was estimated to be worth US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-01-18
Pages: 128
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2025
The global market for Crude Heparin was valued at US$ 3640 million in the year 2024 and is projected to reach a revised size of US$ 5148 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-18
Pages: 88
USD 2900.00 (Single User License)Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 155
USD 5900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Crude Heparin market size was US$ 3640 million in 2024 and is forecast to a readjusted size of US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 100
USD 4250.00 (Single User License)Global Crude Heparin Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Crude Heparin market is projected to grow from US$ 3640 million in 2024 to US$ 5148 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-10
Pages: 164
USD 4900.00 (Single User License)Crude Heparin- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Crude Heparin was estimated to be worth US$ 3809 million in 2025 and is projected to reach US$ 5387 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 112
USD 3950.00 (Single User License)Global Crude Heparin Market Research Report 2026
The global Crude Heparin market was valued at US$ 3809 million in 2025 and is anticipated to reach US$ 5387 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-01-04
Pages: 124
USD 2900.00 (Single User License)Global Crude Heparin Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Crude Heparin market size was US$ 3809 million in 2025 and is forecast to reach a readjusted size of US$ 5387 million by 2032 with a CAGR of 5.1% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 95
USD 4250.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
Market Segmentation
QYResearch's Strengths
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
Interest In This Report?
Get A Free Sample
Pre-Order Enquiry
OR
Need a Tailored Report?
Customize this report to your needs.
Customize This Report
Fact Checked
Cite this Research